MicroRNAs dysregulation and mitochondrial dysfunction in neurodegenerative diseases

M Catanesi, M d'Angelo, MG Tupone… - International Journal of …, 2020 - mdpi.com
Neurodegenerative diseases are debilitating and currently incurable conditions causing
severe cognitive and motor impairments, defined by the progressive deterioration of …

Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence

V Leta, KR Chaudhuri, O Milner, G Chung-Faye… - Brain, Behavior, and …, 2021 - Elsevier
There is increasing evidence highlighting the potential role of the gut-brain axis in the
pathogenesis of Parkinson's disease (PD) and on the use of probiotics as a therapeutic …

[HTML][HTML] Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson's disease models

V Castelli, M d'Angelo, F Lombardi, M Alfonsetti… - Aging (albany …, 2020 - ncbi.nlm.nih.gov
Parkinson is a common neurodegenerative disorder, characterized by motor and non-motor
symptoms, including abnormalities in the gut function, which may appear before the motor …

[HTML][HTML] Bladder cancer immunotherapy by BCG is associated with a significantly reduced risk of Alzheimer's disease and Parkinson's disease

D Klinger, BL Hill, N Barda, E Halperin, ON Gofrit… - Vaccines, 2021 - mdpi.com
Bacillus Calmette–Guerin (BCG) is a live attenuated form of Mycobacterium bovis that was
developed 100 years ago as a vaccine against tuberculosis (TB) and has been used ever …

Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases

Z Kovács, B Brunner, C Ari - Nutrients, 2021 - mdpi.com
Life expectancy of humans has increased continuously up to the present days, but their
health status (healthspan) was not enhanced by similar extent. To decrease enormous …

Activation of liver X receptors and peroxisome proliferator-activated receptors by lipid extracts of brown seaweeds: a potential application in Alzheimer's disease?

N Martens, N Zhan, G Voortman, FPJ Leijten… - Nutrients, 2023 - mdpi.com
The nuclear liver X receptors (LXRα/β) and peroxisome proliferator-activated receptors
(PPARα/γ) are involved in the regulation of multiple biological processes, including lipid …

Role of JAK-STAT and PPAR-gamma signalling modulators in the prevention of autism and neurological dysfunctions

R Khera, S Mehan, S Kumar, P Sethi, S Bhalla… - Molecular …, 2022 - Springer
The Janus-kinase (JAK) and signal transducer activator of transcription (STAT) signalling
pathways regulate gene expression and control various factors involved in normal …

Peroxisome proliferator-activated receptor-gamma (PPAR-ɣ): molecular effects and its importance as a novel therapeutic target for cerebral ischemic injury

A Mannan, N Garg, TG Singh, HK Kang - Neurochemical Research, 2021 - Springer
Cerebral ischemic injury is a leading cause of death and long-term disability throughout the
world. Peroxisome proliferator-activated receptor gamma (PPAR-ɣ) is a ligand-activated …

[PDF][PDF] Protective effects of pioglitazone on cognitive impairment and the underlying mechanisms: A review of literature

A Alhowail, R Alsikhan, M Alsaud… - Drug Design …, 2022 - Taylor & Francis
Pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, is
known to have anti-inflammatory and anti-oxidant effects on the brain, and its clinical …

Repurposing of anti-diabetic agents as a new opportunity to alleviate cognitive impairment in neurodegenerative and neuropsychiatric disorders

Q Chen, T Cao, NN Li, C Zeng, S Zhang… - Frontiers in …, 2021 - frontiersin.org
Cognitive impairment is a shared abnormality between type 2 diabetes mellitus (T2DM) and
many neurodegenerative and neuropsychiatric disorders, such as Alzheimer's disease (AD) …